Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.291 USD | -0.34% |
|
+6.99% | -94.45% |
Jul. 01 | Lyra Therapeutics, Inc.(NasdaqGM:LYRA) added to Russell Small Cap Comp Value Index | CI |
Jul. 01 | Lyra Therapeutics, Inc.(NasdaqGM:LYRA) added to Russell Small Cap Completeness Index | CI |
Financials (USD)
Sales 2024 * | 1.58M | Sales 2025 * | 807K | Capitalization | 17.74M |
---|---|---|---|---|---|
Net income 2024 * | -87M | Net income 2025 * | -86M | EV / Sales 2024 * | 11.2 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 22 x |
P/E ratio 2024 * |
-0.23
x | P/E ratio 2025 * |
-0.28
x | Employees | 109 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.37% |
Latest transcript on Lyra Therapeutics, Inc.
1 day | -0.34% | ||
1 week | +6.99% | ||
Current month | +5.17% | ||
1 month | -6.16% | ||
3 months | -94.49% | ||
6 months | -94.59% | ||
Current year | -94.45% |
![Extreme 0.2611](/images/extremecours_fleche.png)
![Extreme 0.2532](/images/extremecours_fleche.png)
![Extreme 0.2532](/images/extremecours_fleche.png)
![Extreme 0.2532](/images/extremecours_fleche.png)
![Extreme 0.2532](/images/extremecours_fleche.png)
![Extreme 0.2532](/images/extremecours_fleche.png)
![Extreme 0.2532](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Maria Palasis
CEO | Chief Executive Officer | 59 | 14-12-31 |
Jason Cavalier
DFI | Director of Finance/CFO | 51 | 21-09-12 |
Richard Nieman
CTO | Chief Tech/Sci/R&D Officer | 61 | 22-07-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Harlan Waksal
CHM | Chairman | 71 | 22-02-15 |
W. Smith
BRD | Director/Board Member | 68 | 19-11-18 |
James Tobin
BRD | Director/Board Member | 79 | 22-03-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-12 | 0.291 | -0.34% | 1,212,562 |
24-07-11 | 0.292 | -0.24% | 1,820,662 |
24-07-10 | 0.2927 | +7.93% | 791,908 |
24-07-09 | 0.2712 | +0.74% | 1,307,224 |
24-07-08 | 0.2692 | -1.03% | 1,547,754 |
Delayed Quote Nasdaq, July 12, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-94.45% | 17.74M | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- LYRA Stock